Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction.

Atherosclerosis High-risk plaque Myocardial infarction Non-culprit Optical coherence tomography (OCT) Sex Thin-cap fibroatheroma (TCFA)

Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
22 Aug 2024
Historique:
received: 04 06 2024
revised: 12 07 2024
accepted: 21 08 2024
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: aheadofprint

Résumé

Recurrent events after myocardial infarction (MI) are common and often originate from native non-culprit (NC) lesions that are non-flow limiting. These lesions consequently pose as targets to improve long-term outcome. It is, however, largely unknown whether these lesions differ between sexes. The aim of this study was to assess such potential differences. From the PECTUS-obs study, we assessed sex-related differences in plaque characteristics of fractional flow reserve (FFR)-negative intermediate NC lesions in 420 MI-patients. Among the included patients, 80 (19.1 %) were female and 340 (80.9 %) male. Women were older and more frequently had hypertension and diabetes. In total, 494 NC lesions were analyzed. After adjustment for clinical characteristics and accounting for within-patients clustering, lesion length was longer in female patients (20.8 ± 10.0 vs 18.3 ± 8.5 mm, p = 0.048) and minimum lumen area (2.30 ± 1.42 vs 2.78 ± 1.54 mm FFR-negative NC lesions after MI harbored more high-risk plaque features in female patients. Although this did not translate into an excess of recurrent events in female patients in this modestly sized cohort, it remains to be investigated whether this difference affects clinical outcome.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Recurrent events after myocardial infarction (MI) are common and often originate from native non-culprit (NC) lesions that are non-flow limiting. These lesions consequently pose as targets to improve long-term outcome. It is, however, largely unknown whether these lesions differ between sexes. The aim of this study was to assess such potential differences.
METHODS METHODS
From the PECTUS-obs study, we assessed sex-related differences in plaque characteristics of fractional flow reserve (FFR)-negative intermediate NC lesions in 420 MI-patients.
RESULTS RESULTS
Among the included patients, 80 (19.1 %) were female and 340 (80.9 %) male. Women were older and more frequently had hypertension and diabetes. In total, 494 NC lesions were analyzed. After adjustment for clinical characteristics and accounting for within-patients clustering, lesion length was longer in female patients (20.8 ± 10.0 vs 18.3 ± 8.5 mm, p = 0.048) and minimum lumen area (2.30 ± 1.42 vs 2.78 ± 1.54 mm
CONCLUSIONS CONCLUSIONS
FFR-negative NC lesions after MI harbored more high-risk plaque features in female patients. Although this did not translate into an excess of recurrent events in female patients in this modestly sized cohort, it remains to be investigated whether this difference affects clinical outcome.

Identifiants

pubmed: 39241345
pii: S0021-9150(24)01140-7
doi: 10.1016/j.atherosclerosis.2024.118568
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118568

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Rick H J A Volleberg (RHJA)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Jan-Quinten Mol (JQ)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Anouar Belkacemi (A)

Department of Cardiology, AZ West Hospital, Veurne, Belgium.

Renicus S Hermanides (RS)

Department of Cardiology, Isala Hospital, Zwolle, the Netherlands.

Martijn Meuwissen (M)

Department of Cardiology, Amphia Hospital, Breda, the Netherlands.

Alexey V Protopopov (AV)

Cardiovascular Center of Regional State Hospital, Krasnoyarsk, Russia; Krasnoyarsk State Medical University, Krasnoyarsk, Russia.

Peep Laanmets (P)

Cardiology Center, North Estonia Medical Center, Tallinn, Estonia.

Oleg V Krestyaninov (OV)

Meshalkin National Medical Research Center, Novosibirsk, Russia.

Robert Dennert (R)

Department of Cardiology, Dr. Horacio E. Oduber Hospital, Oranjestad, Aruba.

Rohit M Oemrawsingh (RM)

Department of Cardiology, Amphia Hospital, Breda, the Netherlands; Department of Cardiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.

Jan-Peter van Kuijk (JP)

Department of Cardiology, Sint Antonius Hospital, Nieuwegein, the Netherlands.

Karin Arkenbout (K)

Department of Cardiology, Tergooi Hospital, Blaricum, the Netherlands.

Dirk J van der Heijden (DJ)

Department of Cardiology, Isala Hospital, Zwolle, the Netherlands; Department of Cardiology, Haaglanden Medical Center, The Hague, the Netherlands.

Saman Rasoul (S)

Department of Cardiology, Zuyderland Medical Center, Heerlen, the Netherlands; Department of Cardiology, MUMC+, Maastricht, the Netherlands.

Erik Lipsic (E)

Department of Cardiology, University Medical Center Groningen, Groningen, the Netherlands.

Laura Rodwell (L)

Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Medical Center, Nijmegen, the Netherlands.

Cyril Camaro (C)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Peter Damman (P)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Tomasz Roleder (T)

Faculty of Medicine Wrocław University of Science and Technology, Department of Cardiology, Regional Specialist Hospital, Wrocław, Poland.

Elvin Kedhi (E)

Department of Cardiology, McGill University Health Center, Royal Victoria Hospital, Montreal, Canada.

Maarten A H van Leeuwen (MAH)

Department of Cardiology, Isala Hospital, Zwolle, the Netherlands.

Robert-Jan M van Geuns (RM)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.

Niels van Royen (N)

Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Niels.vanRoyen@radboudumc.nl.

Classifications MeSH